318 related articles for article (PubMed ID: 34059078)
1. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.
Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H
J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078
[TBL] [Abstract][Full Text] [Related]
2. Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques.
Alaarg A; Zheng KH; van der Valk FM; da Silva AE; Versloot M; van Ufford LC; Schulte DM; Storm G; Metselaar JM; Stroes ES; Hamers AA
Vascul Pharmacol; 2016 Jul; 82():51-9. PubMed ID: 27189780
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
[TBL] [Abstract][Full Text] [Related]
4. Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.
Wu T; Chen X; Wang Y; Xiao H; Peng Y; Lin L; Xia W; Long M; Tao J; Shuai X
Nanomedicine; 2018 Oct; 14(7):2215-2226. PubMed ID: 29964220
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of ulcerative colitis
Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis.
Mu D; Li J; Qi Y; Sun X; Liu Y; Shen S; Li Y; Xu B; Zhang B
J Nanobiotechnology; 2020 Dec; 18(1):179. PubMed ID: 33287831
[TBL] [Abstract][Full Text] [Related]
7. Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy.
Chen X; Dai C; Hu R; Yu L; Chen Y; Zhang B
J Mater Chem B; 2023 Mar; 11(9):1881-1890. PubMed ID: 36723250
[TBL] [Abstract][Full Text] [Related]
8. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.
Gieseg SP; Crone EM; Flavall EA; Amit Z
Br J Pharmacol; 2008 Feb; 153(4):627-35. PubMed ID: 17700723
[TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
10. Liver Fibrosis Amelioration by Macrophage-Biomimetic Polydopamine Nanoparticles via Synergistically Alleviating Inflammation and Scavenging ROS.
Ma Z; Tian X; Yu S; Shu W; Zhang C; Zhang L; Wang F
Mol Pharm; 2024 Jun; 21(6):3040-3052. PubMed ID: 38767388
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
12. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice.
Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W
Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum triterpenoids and polysaccharides attenuate atherosclerotic plaque in high-fat diet rabbits.
Li Y; Tang J; Gao H; Xu Y; Han Y; Shang H; Lu Y; Qin C
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1929-1938. PubMed ID: 33992512
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
15. The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.
Ou H; Huang Z; Mo Z; Xiao J
Cardiovasc Toxicol; 2017 Jan; 17(1):1-12. PubMed ID: 27350146
[TBL] [Abstract][Full Text] [Related]
16. Anti-atherosclerotic molecules targeting oxidative stress and inflammation.
Adameova A; Xu YJ; Duhamel TA; Tappia PS; Shan L; Dhalla NS
Curr Pharm Des; 2009; 15(27):3094-107. PubMed ID: 19754384
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target.
El Hadri K; Smith R; Duplus E; El Amri C
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008500
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice.
Sun GB; Qin M; Ye JX; Pan RL; Meng XB; Wang M; Luo Y; Li ZY; Wang HW; Sun XB
Toxicol Appl Pharmacol; 2013 Aug; 271(1):114-26. PubMed ID: 23639522
[TBL] [Abstract][Full Text] [Related]
19. Cluster of Differentiation-44-Targeting Prussian Blue Nanoparticles Onloaded with Colchicine for Atherosclerotic Plaque Regression in a Mice Model.
Zhu Y; Fang Y; Wang Y; Han D; Liu J; Tian L; Xu M; Wang Y; Cao F
ACS Biomater Sci Eng; 2024 Mar; 10(3):1530-1543. PubMed ID: 38372216
[TBL] [Abstract][Full Text] [Related]
20. Modulating Lipoprotein Transcellular Transport and Atherosclerotic Plaque Formation in ApoE
Di Francesco V; Gurgone D; Palomba R; Ferreira MFMM; Catelani T; Cervadoro A; Maffia P; Decuzzi P
ACS Appl Mater Interfaces; 2020 Aug; 12(34):37943-37956. PubMed ID: 32805983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
